Targeted Cancer Therapies and QT Interval Prolongation: Unveiling the Mechanisms Underlying Arrhythmic Complications and the Need for Risk Stratification Strategies-Reference-Cited by-同舟云学术

Targeted Cancer Therapies and QT Interval Prolongation: Unveiling the Mechanisms Underlying Arrhythmic Complications and the Need for Risk Stratification Strategies

Published:2016-09-14 Issue:2 Volume:37 Page:121-134
ISSN:1173-2563
Container-title:Clinical Drug Investigation
language:en
Short-container-title:Clin Drug Investig

Author:

Cuni Rezarta^ORCID,Parrini Iris,Asteggiano Riccardo,Conte Maria Rosa

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s40261-016-0460-5.pdf

Reference82 articles.

1. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2014;136(5):E359–86. doi: 10.1002/ijc.29210 .

2. Suter TM, Ewer MS. Cancer drugs and the heart: importance and management. Eur Heart J. 2013;34(15):1102–11. doi: 10.1093/eurheartj/ehs181 .

3. Curigliano G, Cardinale D, Suter T, Plataniotis G, de Azambuja E, Sandri MT, ESMO Guidelines Working Group, et al. Cardiovascular toxicity induced by chemotherapy, targeted agents and radiotherapy: ESMO Clinical Practice Guidelines. Ann Oncol. 2012;23(Suppl 7):vii155–66. doi: 10.1093/annonc/mds293 .

4. Raschi E, de Ponti F. Cardiovascular toxicity of anticancer-targeted therapy: emerging issues in the era of cardio-oncology. Intern Emerg Med. 2012;7(2):113–31. doi: 10.1007/s11739-011-0744-y .

5. Raschi E, Vasina V, Ursino MG, Boriani G, Martoni A, de Ponti F. Anticancer drugs and cardiotoxicity: insights and perspectives in the era of targeted therapy. Pharmacol Ther. 2010;125(2):196–218. doi: 10.1016/j.pharmthera.2009.10.002 .

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Proarrhythmic effects of cancer therapies;In a good rythm;2022-09-30

2. Cardio-Oncology: A Myriad of Relationships Between Cardiovascular Disease and Cancer;Frontiers in Cardiovascular Medicine;2022-03-17

3. Zebrafish Models of Cancer Therapy-Induced Cardiovascular Toxicity;Journal of Cardiovascular Development and Disease;2021-01-22

4. Management of QT Prolongation Induced by Anticancer Drugs;Cardiovascular Complications in Cancer Therapy;2018-10-05

5. Management of QT prolongation induced by anti-cancer drugs: Target therapy and old agents. Different algorithms for different drugs;Cancer Treatment Reviews;2018-02